Standard
Medtronic Post-Approval Study Confirms Long-Term Efficacy and Safety of IN.PACT AV Drug-Coated Balloon for Kidney Disease Patients
The medical technology landscape for end-stage renal disease (ESRD) has reached a significant milestone as Medtronic recently unveiled positive results from its post-approval study of the IN.PACT AV drug-coated balloon (DCB). Presented at the Society of Interventional Radiology’s (SIR) annual meeting, the data reinforces the long-term safety and clinical efficacy of the device, matching the…
